Skip to main content
$0.65 $0.00 (-0.6%)

04:00 PM EDT on 09/28/22

Matinas BioPharma Holdings, Inc. (NYSEMKT:MTNB)

CAPS Rating: 1 out of 5

Current Price $0.65 Mkt Cap $141.0M
Open $0.64 P/E Ratio 0.00
Prev. Close $0.65 Div. (Yield) $0.00 (0.0%)
Daily Range $0.63 - $0.69 Volume 158,839
52-Wk Range $0.49 - $1.45 Avg. Daily Vol. 301,686

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

9 Outperform
17 Underperform
 

All-Star Players

1 Outperform
12 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:MTNB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Puckettjl (< 20)
Submitted June 29, 2020

They have a new drug coming up on Stage 3 clinical trials with another on deck for 2021.

kdakota630 (33.87)
Submitted March 01, 2019

Whoa, Nellie, not so fast fella. Look out below. No way! Back to reality. Not a good pick. Not now. Wrong logic at this point. Gravity calls. Watch out on this one. Not at all optimistic. Pessimism reigns. Downward trend continues. Likely to continue… More

NYSEMKT:MTNB Summary

Fools bullish on NYSEMKT:MTNB are also bullish on:

Fools bearish on NYSEMKT:MTNB are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about MTNB.

Recs

1
Member Avatar Puckettjl (< 20) Submitted: 6/29/2020 9:25:37 AM : Outperform Start Price: $0.84 NYSE MKT:MTNB Score: -45.96

They have a new drug coming up on Stage 3 clinical trials with another on deck for 2021.

Recs

2
Member Avatar hatch23 (< 20) Submitted: 6/16/2020 2:40:41 PM : Outperform Start Price: $0.85 NYSE MKT:MTNB Score: -43.34

They have at least 4 drugs in trials including MAT9001, a prescription only omega 3 fatty acid compound.(fish oil) Amarin ran up to 26 on its approval of Vascepa. Enhance-It trial is going on now(resumes in June) where they are comparing Mat9001 to Vascepa.

Recs

1
Member Avatar kdakota630 (33.87) Submitted: 3/1/2019 1:21:34 PM : Underperform Start Price: $1.44 NYSE MKT:MTNB Score: +87.59

Whoa, Nellie, not so fast fella. Look out below. No way! Back to reality. Not a good pick. Not now. Wrong logic at this point. Gravity calls. Watch out on this one. Not at all optimistic. Pessimism reigns. Downward trend continues. Likely to continue to underperform. More downside imminent. Danger danger, at least for the next month. So obvious. Right direction now. Diminishing in value currently. Not impressive right now. Nonsense stock. Likely to fall in value.

Leaderboard

Find the members with the highest scoring picks in MTNB.

Score Leader

80brown

80brown (99.95) Score: +164.44

The Score Leader is the player with the highest score across all their picks in MTNB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. TSIF 99.98 1/30/2017 1/24/2019 Underperform 1Y $2.15 -69.94% +62.73% +132.67 1 Comment
tsperbeck 98.28 4/28/2017 Underperform 1Y $2.75 -76.50% +55.64% +132.14 0 Comment
comicalmanbeast 65.67 9/25/2017 Underperform 5Y $1.26 -48.71% +48.50% +97.21 0 Comment
kdakota630 33.87 3/1/2019 Underperform 3M $1.44 -55.12% +32.48% +87.59 1 Comment
eruiz285 < 20 1/22/2019 Underperform NS $1.13 -42.81% +39.91% +82.72 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. RayNobleEsq 99.98 12/12/2019 Underperform 5Y $1.70 -61.98% +18.03% +80.02 0 Comment
80brown 99.95 1/22/2019 Underperform 5Y $1.05 -38.45% +41.42% +79.86 0 Comment
liszewski 99.96 11/12/2018 Underperform 5Y $1.20 -46.14% +33.67% +79.81 0 Comment
sscrapeTheStreet 36.19 2/11/2019 Underperform 3M $1.09 -40.71% +36.62% +77.33 0 Comment
RyanCoke 99.94 10/19/2018 Underperform NS $1.01 -35.76% +32.87% +68.62 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MTNB.